Biocomputers could give a boost to precision in medicine with a new wave of cell-based therapies.
The uninsured, the health-illiterate, women, minorities and immigrants constitute the under-represented sections in the datasets.
One of the benefits of such 3D-imagery is that it cuts short the surgical time as surgeons are aware of what to expect.
Genetically engineered red blood cells that can be loaded up with therapeutic proteins in patients battling cancer and other rare conditions.
The outcome of the highly risky and complicated surgery can be gauged only after a few weeks.
Twenty percent of the 60,000 heart scans in the U.K. are misdiagnosed each year.
Algae cells infused with engineered material perform drug delivery.
Technology dramatically shrinks time required to review a patient’s sample.
The idea is to outnumber the fertile males with the sterile ones.
The development is a big step in neuropsychiatric assessment as it opens up the prospects of remote evaluation.
